Sashi-cov-2 antigen mai sauri gwajin kaset

Amfani da aka yi niyya

DaSashi-cov-2 antigen mai sauri gwajin kasetshi ne mai saurin rigakafi ga masu cancanta na gano SARS-COV-2 a cikin kayan aikin halittar mutum- -Kov-2.it an yi niyyar taimakawa a cikin yanayin cutar sadsocialCUTAR COVID 19kamuwa da cuta.

Bayani game da fakiti

Gwaje-gwaje 25 / Shirya, Gwaje-gwaje 50 / Shirya, Gwaje-gwaje 100 / Fakitin

Shigowa da

Da labari mai ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwayar cuta ya kasance na β.CUTAR COVID 19cuta ce mai rauni na numfashi mai rauni Babban bayyanar sun hada da zazzabi, gajiya da bushe tari. Rashin ambaliya, hanci hanci, ciwon makogwaro, myalgia ana samun sa a cikin fewan lokuta.

Sake

Casette Cassette ya ƙunshi anti-Sucur-2-2 nucleocapsid barbashi mai gina jiki da anti-2-2 nucleocapsid furotin mai rufi a kan membrane.

MATAKAN KARIYA

Da fatan za a karanta duk bayanan a cikin wannan kunshin sakawa kafin yin gwajin.

1.Wor kwararru a cikin amfani da bincike na vitro kawai. Karka yi amfani da ranar karewa.

2. Shawar ya tabbata a aljihunan da aka rufe har a shirye don amfani.

3. Anall samfurori ya kamata a duba yiwuwar haɗari da kulawa da shi a matsayin wakili na kamuwa da cuta.

4. Yakamata a jefar gwajin da aka yi amfani da shi bisa ga ka'idojin gida.

5.avoid ta amfani da samfuran jini.

6. Albarau sankara Wen suna ɗaukar samfurori, gujewa ta taɓa membrane da samfurin da kyau.

Adana da kwanciyar hankali

Lokacin ingancin shine watanni 18 idan an adana wannan samfurin a cikin yanayin

2-30 ℃ .The gwajin gwaji ne ta hanyar karewar ranar karewa a kan aljihunan da aka rufe.The gwajin dole ya kasance a cikin aljihun da aka rufe har sai amfani.Do ba daskare.Kar a yi amfani da ranar karewa.

Samfuran samfuran da kuma iyo

1. Fetrative tarin rauni: Sanya wani bakararre swab a cikin bakin, daga cikin bakin bango da bango na palaryzaal tare da matsakaici

karfi, kauce wa ta taɓa harshen kuma cire swab.

2.Ko samfurin nan da nan tare da maganin hakar samfurin da aka bayar a cikin kit ɗin bayan samfurin an tattara. Idan ba za a iya sarrafa shi nan da nan, ya kamata a adana samfurin a cikin bushe, haifuwa da tsananin bututun filastik da aka rufe. Ana iya adanar shi a 2-8 ℃ don 8 hours, kuma ana iya adana na dogon lokaci A -70 ℃.

3. Samfurori da aka gurbata su ta hanyar sharan abinci na baka na baka don gwada wannan samfurin. Samfuran da aka tattara daga swabs waɗanda suke da karfin tunani ko agglomerated ba da shawarar yin gwaji da wannan samfurin. Idan swabs sun gurbata da yawan jini, ba a bada shawarar su gwada. Ba'a bada shawarar yin amfani da samfuran da aka sarrafa tare da hakar samfurin ba a bayar da a cikin wannan kit ɗin don gwada wannan samfurin ba.

Kayan aikin Kit

Kayan da aka bayar

Abubuwan da ake buƙata amma ba su ba da

Bayani na25

Gwaji / fakiti50

Gwaji / Pack100

Gwaje-gwaje / fakitin hakar Gwaji

Gwaje-gwaje na Tube / Packet50 Gwaje-gwaje / Pack≥ Gwaji / Pretinsstred zuwa

packserenser ga

packserenser ga

ƙunshi

Kwatance don amfani

Bada izinin gwajin, samfurin, haɓakar buffer don daidaita yawan zafin jiki (15-30 ℃) kafin gwaji.

1.revove Cassette Cassette daga aljihun da aka rufe da amfani da shi cikin mintina 15. Za a samu sakamako mafi kyau idan an yi assay nan da nan bayan bude aljihun tsare.

2. Sankon hakar a cikin tashar aikin: Rage hakar gaba da kwalban a tsaye.

3. Accoun ɗin SWAB samfurin a cikin hakar bututu.rotate swab na kusan sakan 10 yayin da yake latsa kansa a cikin bututun a cikin swab.

4.Amawo da Swab yayin da yake matse da swab shugaban da na hakar yayin da kake cire swab da yawa gwargwadon ka'idodin zina biohar.

5.Fit the Droper Tip a saman bututun mai karawa.

6.Add 2 saukad da mafita (kimanin, 65μl) zuwa samfurin da kyau sannan kuma fara lokacin sakamakon a cikin mintina 30, kuma ana karanta sakamakon bayan minti 30 ba shi da inganci.

Fassarar sakamako

Layin launuka daya ya bayyana a yankin mai sarrafawa (C). Babu layi ɗaya da alama a cikin yankin gwajin (T) .A mara kyau sakamako yana nuna cewa SSS-2 Antigen ba a cikin ƙirar gwajin ba.

MSakamakon:

Lines biyu da aka bayyana.one launuka masu launi ya kamata ya kasance a cikin yankin sarrafawa (c) da wani sakamako mai launi na gwaji ya kamata ya kasance a cikin yankin gwaji (T).

Sakamakon ba tare da amfani ba:

Layin sarrafawa ya gaza bayyana don bayyana adadin bayanan samfuri ko kuma dabarun ingantaccen tsari shine mafi yawan dalilai na sarrafawa. Yi bita da hanya kuma maimaita gwajin tare da sabon gwaji. Idan matsalar ta ci gaba, dakatar da amfani da Kit ɗin gwajin nan da nan da kuma tuntuɓi mai bautar gida.

SAURARA:

Daɗaɗa launi a yankin layin gwaji (t) zai bambanta dangane da taro SARS-2-2 Antigen ya gabatar a cikin samfuran. Saboda haka, duk inuwa mai launi a yankin layin gwaji (T) ya kamata a yi la'akari da tabbatacce.

Iko mai inganci

• An haɗa ikon sarrafawa a cikin gwajin. Ana ganin layin da aka canza a cikin yankin sarrafawa (C) yana ɗaukar hoto na ciki.it tabbatar da isasshen membrane wicking.
• Ba a kawo ka'idodin sarrafawa tare da wannan kit ɗin ba; Koyaya, ana ba da shawarar cewa za a gwada tabbataccen iko da mara kyau azaman kyakkyawan dakin gwaje-gwaje don tabbatar da hanyar gwajin kuma don tabbatar da aikin gwajin da ya dace.

IyakanceNa gwaji

1. SARS-COV-2 Antigen antigen na gwaji mai sauri na Cassette ne don amfani da bincike na Vitro kawai.
2. Daidaitawar gwajin ya dogara da ingancin samfurin SWab.
3. ABARS-2 COV-2 Angen Antigen gwajin gwaji zai nuna kasancewar SARS-CoV-2 a cikin samfuran SSS mai ma'ana da kuma corwararrun magungunan da ba shi da ma'ana.
4. Kamar yadda tare da duk gwaje-gwajen bincike, dole ne a fassara duk sakamakon tare tare da sauran bayanan asibiti masu ilimi.
5. Sakamakon mummunan sakamako wanda aka samu daga wannan kit ɗin ya kamata a tabbatar da sakamakon PCR.a idan da aka tattara sakamakon SARS-2 a cikin swab bai isa ba ko kuma yana ƙasa da lalacewar gwajin.
6. Yawan jini ko gamsai a kan samfuran swab samfuri na iya tsangar da aiki kuma yana iya samar da sakamako mai kyau na karya.
7. Sakamakon sakamako ga SARS-Cov-2 ba ya hana wani co-kamuwa da cuta tare da anther pathogen. Saboda haka yiwuwar yiwuwar cututtukan ƙwayar cuta ya kamata a la'akari.
8. Sakamakon sakamako mara kyau Kada kuyi watsi da kamuwa da shi-cof-2, musamman a cikin waɗanda suka kasance tare da cutar. Dole ne a yi gwaji da gwaji tare da kwayoyin kwayar cutar kwayar cuta ta magance kamuwa da cuta a cikin wadannan mutane.
9. Tasirin sakamako na iya zama saboda halin da kamuwa da cuta tare da rashin-COV-2 Coronavirus, kamar coronavirus Hku1, NL63, OC43, ko 229e.
10. Sakamako daga Antigen Gwajin bai kamata a yi amfani da shi a matsayin kawai tushen ganowa ko cire kamuwa da SARK-cov-2 ko don sanar da yanayin kamuwa da cuta ba.
11. Sake sake dawowa yana da ikon kashe kwayar, amma ba zai iya dakatar da kashi 100% na cutar ba.

Halaye na aiki

Ji na ƙwaraidaBAYANIN

An yi amfani da COV-2 COV-2 Casette Cursete tare da samfuran da aka samu daga cikin marasa lafiya na Gwajin Gwajin Gwajin Gwaji

Dangi na dangi: 95.0% (95% ci *: 83.1% -99.4%)

Dangi da dama: 99.2% (95% ci *: 97.6% -99.8%)

* Dogara ta Tsaro

Iyakar ganowa

Lokacin da kwayar cutar ta fi 400tcid₅₀/ ml, ƙimar gano tushe ta fi 95%. Lokacin da abun cikin kwayar cuta ba kasa da 200tcid₅₀/ ml, ƙimar gano tushe ƙasa da kashi 95%, don haka mafi ƙarancin gano wannan samfurin shine 400Tcid₅₀/ ml.

Daidaici

Uku a jere an gwada don daidaito. An yi amfani da batuna daban-daban na reagents don gwada samfurin daidai sau 10 cikin nasara, kuma sakamakon yana da kyau. An yi amfani da batuna daban-daban na reagents don gwada samfurin daidai sau 10 cikin nasara, kuma sakamakon duk yake da kyau.

Tasirin ƙugiya

Lokacin da abun ciki abun ciki a cikin samfurin da za a gwada shi ya kai 4.0 * 10⁵Tcid₅₀/ ml, sakamakon gwajin har yanzu bai nuna tasirin ƙugiya ba.

Giciye-maimaitawa

An kimanta abubuwan da aka kimanta kayan aikin. Sakamakon binciken bai nuna tsallakewa tare da maballin mai zuwa ba.

IAbubuwa masu narkewa

Sakamakon gwajin ba zai iya yin ta hanyar amfani da abu ba a cikin masu tattarawa:

Bayani

1.weiss SR, Leibowitz Jz.Coronvirus Pathogenesis. Advus res 2011; 81: 85-164
2.cui J, Li Z, Shi Zl.origin da kuma juyin halitta na cutar pathogenic coronaviroluses.nat Rev Micobiolol 2019; 17: 181-192.
3.su s, wong g, shi w, et et al-et al.fiidimoology, lamunin kwayoyin halitta, da pathogene na coronaviruses. Na zamani; 24: 490-502.